Clinical Trials Browser

Completed × Breast Neoplasms, Male × Sorafenib × Clear all

NCT00096434 2024-03-07

Sorafenib in Treating Patients With Metastatic Breast Cancer

Phase 2 Completed

Breast Neoplasms, Breast Neoplasms, Male